PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
2026-07-14T    Biotechnology   Environmental Products & Services 
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction
2026-07-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
2026-07-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
STATEMENT FROM THE RIGMORA BIOTECH INVESTORS
2026-07-14T    Banking/Financial Service   Biotechnology   Legal issues 
Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities
2026-07-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence
2026-07-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China
2026-07-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
2026-07-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved